articleTop 1% cited

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only

Vaccine · 2006 · Vol. 24(33-34) · pp. 5937–5949

Sandro Giannini✉(GlaxoSmithKline (Belgium))Emmanuel Hanon(GlaxoSmithKline (Belgium))Philippe Moris(GlaxoSmithKline (Belgium))Maxime Vanmechelen(GlaxoSmithKline (Belgium))S. Morel(GlaxoSmithKline (Belgium))Francis Dessy(GlaxoSmithKline (Belgium))Marc Fourneau(GlaxoSmithKline (Belgium))Brigitte Colau(GlaxoSmithKline (Belgium))Jon SuzichG LOSONKSY

View via DOI Publisher page

Immune Response and Inflammation Immunotherapy and Immune Responses Antimicrobial Peptides and ActivitiesAdjuvantImmune systemELISPOTVaccinationAntibodyHumoral immunityVirologyImmunologyBiologyMemory B cell

MeSH terms

Adjuvants, ImmunologicAdolescentAdultAnimalsAntibodies, ViralB-LymphocytesCell LineEnzyme-Linked Immunosorbent AssayFemaleHumansImmunologic MemoryLipid AMacaca mulattaMice, Inbred BALB CMonocytes

Citations

496

FWCI

13.02

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

TLR-based immune adjuvants